arrow_back Back to App

Report on Nonprofit Pharmaceutical Organizations and Drug Costs

Congress has requested a report on nonprofit pharmaceutical organizations. The report will examine how these organizations could impact the availability and cost of medicines for citizens and potentially speed up the development of new treatments. The goal is to explore ways to make medicines more affordable and accessible.
Key points
Study ordered on the impact of nonprofit pharmaceutical organizations on drug prices and availability.
Report to examine if nonprofits can accelerate the development of new drugs and therapies.
Analysis to identify barriers for these organizations and potential actions by Congress to improve the drug market.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_4341
Sponsor: Sen. Rosen, Jacky [D-NV]
Process start date: 2022-05-26